Advertisement

Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline

      Abstract

      Background

      Docosahexaenoic acid (DHA) plays an important role in neural function. Decreases in plasma DHA are associated with cognitive decline in healthy elderly adults and in patients with Alzheimer's disease. Higher DHA intake is inversely correlated with relative risk of Alzheimer's disease. The potential benefits of DHA supplementation in age-related cognitive decline (ARCD) have not been fully examined.

      Objective

      Determine effects of DHA administration on improving cognitive functions in healthy older adults with ARCD.

      Methods

      Randomized, double-blind, placebo-controlled, clinical study was conducted at 19 U.S. clinical sites. A total of 485 healthy subjects, aged ≥55 with Mini-Mental State Examination >26 and a Logical Memory (Wechsler Memory Scale III) baseline score ≥1 standard deviation below younger adults, were randomly assigned to 900 mg/d of DHA orally or matching placebo for 24 weeks. The primary outcome was the CANTAB Paired Associate Learning (PAL), a visuospatial learning and episodic memory test.

      Results

      Intention-to-treat analysis demonstrated significantly fewer PAL six pattern errors with DHA versus placebo at 24 weeks (difference score, −1.63 ± 0.76 [−3.1, −0.14, 95% CI], P = .03). DHA supplementation was also associated with improved immediate and delayed Verbal Recognition Memory scores (P < .02), but not working memory or executive function tests. Plasma DHA levels doubled and correlated with improved PAL scores (P < .02) in the DHA group. DHA was well tolerated with no reported treatment-related serious adverse events.

      Conclusions

      Twenty-four week supplementation with 900 mg/d DHA improved learning and memory function in ARCD and is a beneficial supplement that supports cognitive health with aging.

      Trial Registration

      Clinicaltrials.gov, Identifier: NCT0027813.

      Keywords

      To read this article in full you will need to make a payment

      References

      1. Alzheimer's Association. Alzheimer's disease and maintaining brain and memory health national survey results, 2004. Available at http://www.alz.org/alzheimers_disease_publications_reports.asp. Accessed February 15, 2005.

        • Plassman B.L.
        • Langa K.M.
        • Fisher G.G.
        • Heeringa S.G.
        • Weir D.R.
        • Ofstedal M.B.
        • et al.
        Prevalence of cognitive impairment without dementia in the United States.
        Ann Intern Med. 2008; 148: 427-434
        • Heude B.
        • Ducimetiere P.
        • Berr C.
        Cognitive decline and fatty acid composition of erythrocyte membranes—The EVA study.
        Am J Clin Nutr. 2003; 77: 803-808
        • Beydoun M.A.
        • Kaufman J.S.
        • Satia J.A.
        • Rosamond W.
        • Folsom A.R.
        Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study.
        Am J Clin Nutr. 2007; 85: 1103-1111
        • Conquer J.A.
        • Tierney M.C.
        • Zecevic J.
        • Bettger W.J.
        • Fisher R.H.
        Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment.
        Lipids. 2000; 35: 1305-1312
        • Schaefer E.J.
        • Bongard V.
        • Beiser A.S.
        • Lamon-Fava S.
        • Robins S.J.
        • Au R.
        • et al.
        Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study.
        Arch Neurol. 2006; 63: 1545-1550
        • Noel K.
        • Hoffman J.
        • Ellis L.
        • Yurko-Mauro K.
        • Cella C.
        • Sercus B.
        • et al.
        DHA and cognitive function in the elderly: a systematic review of the literature.
        Res Pract Alzheimer's Dis. 2006; 11: 381-387
        • Morris M.C.
        • Evans D.A.
        • Bienias J.L.
        • Tangney C.C.
        • Bennett D.A.
        • Wilson R.S.
        • et al.
        Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease.
        Arch Neurol. 2003; 60: 940-946
        • Kalmijn S.
        • van Boxtel M.P.
        • Ocke M.
        • Verschuren W.M.
        • Kromhout D.
        • Launer L.J.
        Dietary intake of fatty acids and fish in relation to cognitive performance at middle age.
        Neurology. 2004; 62: 275-280
        • Lauritzen L.
        • Hansen H.S.
        • Jorgensen M.H.
        • Michaelsen K.F.
        The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina.
        Prog Lipid Res. 2001; 40: 1-94
        • Salem Jr., N.
        • Litman B.
        • Kim H.-Y.
        • Gawrisch K.
        Mechanisms of action of docosahexaenoic acid in the nervous system.
        Lipids. 2001; 36: 945-959
        • Martin D.S.
        • Spencer P.
        • Horrobin D.F.
        • Lynch M.A.
        Long-term potentiation in aged rats is restored when the age-related decrease in polyunsaturated fatty acid concentration is reversed.
        Prostaglandins Leukot Essent Fatty Acids. 2002; 67: 121-130
        • Tsukada H.
        • Kakiuchi T.
        • Fukumoto D.
        • Nishiyama S.
        • Koga K.
        Docosahexaenoic acid (DHA) improves the age-related impairment of the coupling mechanism between neuronal activation and functional cerebral blood flow response: a PET study in conscious monkeys.
        Brain Res. 2000; 862: 180-186
        • Petursdottir A.L.
        • Farr S.A.
        • Morley J.E.
        • Banks W.A.
        • Skuladottir G.V.
        Effect of dietary n-3 polyunsaturated fatty acids on brain lipid fatty acid composition, learning ability, and memory of senescence-accelerated mouse.
        J Gerontol A Biol Sci Med Sci. 2008; 63: 1153-1160
        • Lim G.P.
        • Calon F.
        • Morihara T.
        • Yang F.
        • Teter B.
        • Ubeda O.
        • et al.
        A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model.
        J Neurosci. 2005; 25: 3032-3040
        • Green K.N.
        • Martinez-Coria H.
        • Khashwji H.
        • Hall E.B.
        • Yurko-Mauro K.A.
        • Ellis L.
        • et al.
        Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels.
        J Neurosci. 2007; 27: 4385-4395
        • van de Rest O.
        • Geleijnse J.M.
        • Kok F.J.
        • van Staveren W.A.
        • Dullemeijer C.
        • Olderikkert M.G.
        • et al.
        Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial.
        Neurology. 2008; 71: 430-438
        • Chiu C.C.
        • Su K.P.
        • Cheng T.C.
        • Liu H.C.
        • Chang C.J.
        • Dewey M.E.
        • et al.
        The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study.
        Prog Neuropsychopharmacol Biol Psychiatry. 2008; 32: 1538-1544
        • Freund-Levi Y.
        • Eriksdotter-Jonhagen M.
        • Cederholm T.
        • Basun H.
        • Faxen-Irving G.
        • Garlind A.
        • et al.
        Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
        Arch Neurol. 2006; 63: 1402-1408
        • Wild K.
        • Howieson D.
        • Webbe F.
        • Seelye A.
        • Kaye J.
        Status of computerized cognitive testing in aging: a systematic review.
        Alzheimer's Dement. 2008; 4: 428-437
        • Robbins T.W.
        • James M.
        • Owen A.M.
        • Sahakian B.J.
        • McInnes L.
        • Rabbitt P.
        Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers.
        Dementia. 1994; 5: 266-281
        • de Jager C.A.
        • Milwain E.
        • Budge M.
        Early detection of isolated memory deficits in the elderly: the need for more sensitive neuropsychological tests.
        Psychol Med. 2002; 32: 483-491
        • Cargin J.W.
        • Maruff P.
        • Collie A.
        • Masters C.
        Mild memory impairment in healthy older adults is distinct from normal aging.
        Brain Cogn. 2006; 60: 146-155
        • Small S.A.
        • Tsai W.Y.
        • DeLaPaz R.
        • Mayeux R.
        • Stern Y.
        Imaging hippocampal function across the human life span: is memory decline normal or not?.
        Ann Neurol. 2002; 51: 290-295
        • Egerhazi A.
        • Berecz R.
        • Bartok E.
        • Degrell I.
        Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer's disease.
        Prog Neuropsychopharmacol Biol Psychiatry. 2007; 31: 746-751
        • American Psychiatric Association
        Diagnostic and Statistical Manual of Mental Disorders.
        (4th ed). American Psychiatric Association, Washington, DC1994
        • Crook T.
        • Bartus R.
        • Ferris S.H.
        • Whitehouse P.J.
        • Cohen G.D.
        • Gerston S.
        Age associated memory impairment: proposed diagnostic criteria.
        Dev Neuropsychol. 1986; 2: 261-276
      2. Benisek D, Bailey-Hall E, Oken H, Masayesva S, Arterburn L. Validation of a simple food frequency questionnaire as an indicator of long chain omega-3 intake. In: Inform 2002; Abstracts of the 93rd Annual AOCS Meeting and Expo; 2002; Montreal, Quebec, Canada:S96.

        • Arterburn L.M.
        • Hall E.B.
        • Oken H.
        Distribution, interconversion, and dose response of n-3 fatty acids in humans.
        Am J Clin Nutr. 2006; 83 (1467S–76S)
        • Ryan A.S.
        • Keske M.A.
        • Hoffman J.P.
        • Nelson E.B.
        Clinical overview of algal-docosahexaenoic acid: effects on triglyceride levels and other cardiovascular risk factors.
        Am J Ther. 2009; 16: 183-192
      3. FDA. Agency Response Letter Gras Notification No. GRN000137; February 12 2004.

        • Zelinski E.M.
        • Gilewski M.J.
        A 10-item Rasch modeled memory self-efficacy scale.
        Aging Ment Health. 2004; 8: 293-306
        • Galasko D.
        • Bennett D.A.
        • Sano M.
        • Marson D.
        • Kaye J.
        • Edland S.D.
        ADCS Prevention Instrument Project: assessment of instrumental activities of daily living for community-dwelling elderly individuals in dementia prevention clinical trials.
        Alzheimer Dis Assoc Disord. 2006; 20: S152-S169
        • Folstein M.F.
        • Folstein S.E.
        • McHugh P.R.
        “Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.
        J Psychiatr Res. 1975; 12: 189-198
        • Yesavage J.A.
        • Brink T.L.
        • Rose T.L.
        • Lum O.
        • Huang V.
        • Adey M.
        • et al.
        Development and validation of a geriatric depression screening scale: a preliminary report.
        J Psychiatr Res. 1982; 17: 37-49
        • Arterburn L.M.
        • Oken H.A.
        • Hoffman J.P.
        • Bailey-Hall E.
        • Chung G.
        • Rom D.
        • et al.
        Bioequivalence of docosahexaenoic acid from different algal oils in capsules and in a DHA-fortified food.
        Lipids. 2007; 42: 1011-1024
      4. USDA. Nutrient intakes from food: mean amounts consumed per individual, one day, 2003-2004. USDA, Agricultural Research Service, 2007. Available at http://www.ars.usda.gov/ba/bhnrc/fsrg. Accessed December 17, 2007

        • Lloyd-Jones D.
        • Adams R.
        • Carnethon M.
        • De Simone G.
        • Ferguson T.B.
        • Flegal K.
        • et al.
        Heart Disease and Stroke Statistics—2009 Update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.
        Circulation. 2009; 119: e21-e181
        • Fowler K.S.
        • Saling M.M.
        • Conway E.L.
        • Semple J.M.
        • Louis W.J.
        Paired associate performance in the early detection of DAT.
        J Int Neuropsychol Soc. 2002; 8: 58-71
        • Blackwell A.D.
        • Sahakian B.J.
        • Vesey R.
        • Semple J.M.
        • Robbins T.W.
        • Hodges J.R.
        Detecting dementia: novel neuropsychological markers of preclinical Alzheimer's disease.
        Dement Geriatr Cogn Disord. 2004; 17: 42-48
        • Swainson R.
        • Hodges J.R.
        • Galton C.J.
        • Semple J.
        • Michael A.
        • Dunn B.D.
        • et al.
        Early detection and differential diagnosis of Alzheimer's disease and depression with neuropsychological tasks.
        Dement Geriatr Cogn Disord. 2001; 12: 265-280
        • Stampfer M.J.
        Cardiovascular disease and Alzheimer's disease: common links.
        J Intern Med. 2006; 260: 211-223
        • Mori T.A.
        • Bao D.Q.
        • Burke V.
        • Puddey I.B.
        • Beilin L.J.
        Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans.
        Hypertension. 1999; 34: 253-260